Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder
Patrick M. Brunner(Icahn School of Medicine at Mount Sinai), Alain Taı̈eb(Université de Bordeaux), Amy S. Paller(Northwestern University), Kenji Kabashima(Kyoto University), Emma Guttman‐Yassky(Icahn School of Medicine at Mount Sinai), Michael R. Ardern‐Jones, Mette Deleuran(Aarhus University Hospital), Nick J. Reynolds(Newcastle upon Tyne Hospitals NHS Foundation Trust), M. Bagot(Inserm), Phyllis I. Spuls, Masayuki Amagai(Keio University), Thomas A. Luger(University Hospital Münster), Kilian Eyerich(University Medical Center Freiburg), Georg Stingl(Medical University of Vienna), Jonathan I. Silverberg(George Washington University), DirkJan Hijnen, Thomas Werfel(Medizinische Hochschule Hannover)
Cited by 377
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
|Frontiers in Oncology|2018|1.3k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2013|1.3k
Guidelines of care for the management of atopic dermatitis
|Journal of the American Academy of Dermatology|2014|1.2k